Complications in Celiac Disease Under Gluten-Free Diet

  • Antonio Tursi
  • Walter Elisei
  • Gian Marco Giorgetti
  • Giovanni Brandimarte
  • Fabio Aiello
Original Article

Abstract

We assessed the onset of malignant and nonmalignant complications in a cohort of celiac disease (CD) patients under gluten-free diet (GFD). Five hundred and forty-nine CD patients were retrospectively assessed. Two hundred and fifty-one (45.7%) showed classical, 262 (47.7%) subclinical, and 36 (6.6%) silent form of CD at the time of the diagnosis. The mean time under GFD was 7.13 years (range 1–15 years). Out of 549 patients, 381 (69.4%) were fully compliant, 112/549 (20.4%) reported less than one dietary transgression/month, and 56/549 (10.2%) reported at least one dietary transgression/month. Out of 549 patients, 18 (3.3%) patients developed complications under GFD (seven malignant and 11 nonmalignant complications). Fourteen patients were previously affected by classical CD (5.6% of the overall patients with classical CD), and four were affected by subclinical CD (1.5% of the overall patients with subclinical CD). None of the patients affected by silent CD developed complications. There was no statistical difference between the mean age of the two groups developing complications (P = n.s.). Complications appeared after a mean time under GFD of 6.5 years in classical CD, and after a mean time of 3.5 years in subclinical CD (P = n.s.). Finally, 6/14 (42.8%) patients with classical CD were not fully compliant to GFD, while 2/4 (50%) of subclinical CD patients were not fully compliant to GFD (P = n.s.). Less than 5% of CD patients may develop complications under GFD. Complications seem to affect more classical CD than subclinical CD, and seem to be irrespective of optimal GFD adherence.

Keywords

Celiac disease Complications Gluten-free diet 

References

  1. 1.
    Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–1753. doi:10.1056/NEJMra071600.PubMedCrossRefGoogle Scholar
  2. 2.
    Martucci S, Biagi F, Di Sabatino A, Corazza GR. Coeliac disease. Dig Liver Dis. 2002;94(suppl2):S150–S153. doi:10.1016/S1590-8658(02)80184-0.CrossRefGoogle Scholar
  3. 3.
    Cinquetti M, Trabucchi C, Menegazzi N, Comucci A, Bressan F, Zoppi G. Psychological problems connetted to the dietary restrictions in the adolescent with coeliac disease. Pediatr Med Chir. 1999;21:279–283.PubMedGoogle Scholar
  4. 4.
    Goddard CJR, Gillet HR. Complications of coeliac disease: are all patients at risk? Postgrad Med J. 2006;82:705–712. doi:10.1136/pgmj.2006.048876.PubMedCrossRefGoogle Scholar
  5. 5.
    Ludvigsson JF, Olén O, Bell M, Ekbom A, Montgomery SM. Coeliac disease and risk of sepsis. Gut. 2008;57:1074–1080. doi:10.1136/gut.2007.133868.PubMedCrossRefGoogle Scholar
  6. 6.
    Cosnes J, Cellier C, Viola S, et al. Groupe D’Etude et de Recherche Sur la Maladie Coeliaque. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol. 2008;6:753–758. doi:10.1016/j.cgh.2007.12.022.PubMedCrossRefGoogle Scholar
  7. 7.
    Jafri MR, Nordstrom CW, Murray JA, et al. Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci. 2008;53:964–971. doi:10.1007/s10620-007-9976-0.PubMedCrossRefGoogle Scholar
  8. 8.
    Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis. 2008;40:46–53. doi:10.1016/j.dld.2007.09.006.PubMedCrossRefGoogle Scholar
  9. 9.
    Meuwisse GH. Diagnostic criteria in coeliac disease. Acta Paediatr. 1970;59:461–463. doi:10.1111/j.1651-2227.1970.tb15545.x.CrossRefGoogle Scholar
  10. 10.
    Walker-Smith JA, Guandalini S, Shmitz J. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of celiac disease. Arch Dis Child. 1990;65:909–911.CrossRefGoogle Scholar
  11. 11.
    United European Gastroenterology. When is a celiac a celiac? A report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol. 2001;13:1123–1128. doi:10.1097/00042737-200109000-00023.CrossRefGoogle Scholar
  12. 12.
    Feighery C, Weir DG, Whelan A, et al. Diagnosis of gluten-sensitive enteropathy: is exclusively reliance on histology appropriate? Eur J Gastroenterol Hepatol. 1998;10:919–925. doi:10.1097/00042737-199811000-00004.PubMedCrossRefGoogle Scholar
  13. 13.
    Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology. 1992;102:330–354.PubMedGoogle Scholar
  14. 14.
    Rostami K, Keckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of anti-endomysium and anti-gliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888–894. doi:10.1111/j.1572-0241.1999.983_f.x.PubMedCrossRefGoogle Scholar
  15. 15.
    Hayat M, Caims A, Dixon MF, O’Mahoney S. Quantitation of intraepithelial lymphocytes in human duodenum; what is normal? J Clin Pathol. 2002;55:393–394.PubMedGoogle Scholar
  16. 16.
    Dickson BC, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists. J Clin Pathol. 2006;59:1008–1016. doi:10.1136/jcp.2005.035345.PubMedCrossRefGoogle Scholar
  17. 17.
    Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–1194. doi:10.1097/00042737-199910000-00019.PubMedCrossRefGoogle Scholar
  18. 18.
    Corrao G, Corazza GR, Bagnardi V, et al. Club del Tenue Study Group. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356–361. doi:10.1016/S0140-6736(01)05554-4.PubMedCrossRefGoogle Scholar
  19. 19.
    Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Regnala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: a 30-year population-based study. Dig Liver Dis. 2006;38:374–380.PubMedCrossRefGoogle Scholar
  20. 20.
    Solaymani-Dodaran M, West J, Logan RF. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol. 2007;102:864–870. doi:10.1111/j.1572-0241.2007.01111.x.PubMedCrossRefGoogle Scholar
  21. 21.
    Haines ML, Anderson R, Gibson PR. Review article: the evidence base for long term management of celiac disease. Aliment Pharmacol Ther. 2008;28:1042–1066.PubMedCrossRefGoogle Scholar
  22. 22.
    Giorgetti GM, Tursi A, Brandimarte G, Anemona L. Small bowel adenocarcinoma as first sign of coeliac disease. Minerva Gastroenterol Dietol. 2002;48:347–350.PubMedGoogle Scholar
  23. 23.
    Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–1435. doi:10.1053/gast.2002.36585.PubMedCrossRefGoogle Scholar
  24. 24.
    Rampertab SD, Forde KA, Green PH. Small bowel neoplasia in coeliac disease. Gut. 2003;52:1211–1214. doi:10.1136/gut.52.8.1211.PubMedCrossRefGoogle Scholar
  25. 25.
    Alcalde M, Carro J, Rivero M, Fernandez JJ, Saenz De Santamaria JS. MALT lymphoma as first clinical presentation of a celiac disease. Acta Gastroenterol Belg. 1998;61:479–482.PubMedGoogle Scholar
  26. 26.
    Tursi A, Inchingolo CD. Synchronous gastric and colonic MALT-lymphoma in coeliac disease: a long-term follow-up on gluten-free diet. Dig Liver Dis. 2007;39:1035–1038. doi:10.1016/j.dld.2006.07.016.PubMedCrossRefGoogle Scholar
  27. 27.
    Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med. 2003;15(115):191–195. doi:10.1016/S0002-9343(03)00302-4.CrossRefGoogle Scholar
  28. 28.
    Cammarota G, Fedeli G, Tursi A, Corazza GR, Gasbarrini G. Coeliac disease and follicular gastritis. Lancet. 1996;347:268. doi:10.1016/S0140-6736(96)90448-1.PubMedCrossRefGoogle Scholar
  29. 29.
    Wolber R, Owen D, Del Buono L, Appelmann H, Freeman H. Lymphocytic gastritis in patients with celiac sprue or sprue-like intestinal disease. Gastroenterology. 1990;98:310–315.PubMedGoogle Scholar
  30. 30.
    Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood. 2007;109:412–421. doi:10.1182/blood-2006-07-031104.PubMedCrossRefGoogle Scholar
  31. 31.
    D’Onofrio F, Miele L, Diaco M, et al. Sjögren’s syndrome in a celiac patient: searching for environmental triggers. Int J Immunopathol Pharmacol. 2006;19:445–448.PubMedGoogle Scholar
  32. 32.
    Rubio-Tapia A, Murray JA. The liver in Celiac Disease. Hepatology. 2007;46:1650–1658. doi:10.1002/hep.21949.PubMedCrossRefGoogle Scholar
  33. 33.
    Grieco A, Mele L, Pignataro G, Pompili M, Rapaccini GL, Gasbarrini G. Is coeliac disease a confounding factor in the diagnosis of NASH? Gut. 2001;49:596. doi:10.1136/gut.49.4.596.PubMedCrossRefGoogle Scholar
  34. 34.
    Bardella MT, Valenti L, Pagliari C, et al. Searching for celiac disease in patients with non-alcoholic fatty liver disease. Dig Liver Dis. 2004;36:333–336. doi:10.1016/j.dld.2004.01.012.PubMedCrossRefGoogle Scholar
  35. 35.
    Tursi A, Brandimarte G, Giorgetti GM. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839–843. doi:10.1111/j.1572-0241.2003.07379.x.PubMedCrossRefGoogle Scholar
  36. 36.
    Wu WC, Zhao W, Li S. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol. 2008;14:313–317. doi:10.3748/wjg.14.313.PubMedCrossRefGoogle Scholar
  37. 37.
    Tata LJ, Card TR, Logan RFA, Hubbard RB, Smith CJP, West J. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology. 2005;128:849–855. doi:10.1053/j.gastro.2005.02.017.PubMedCrossRefGoogle Scholar
  38. 38.
    Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13:163–174. doi:10.1093/humupd/dml054.PubMedCrossRefGoogle Scholar
  39. 39.
    West J, Logan RF, Card TR, Smith C, Hubbard R. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology. 2003;125:429–436. doi:10.1016/S0016-5085(03)00891-6.PubMedCrossRefGoogle Scholar
  40. 40.
    Ludvigsson JF, de Faire U, Ekbom A, Montgomery SM. Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease. Heart. 2007;93:1111–1115. doi:10.1136/hrt.2006.097097.PubMedCrossRefGoogle Scholar
  41. 41.
    Hallert C, Grant C, Grehn S, et al. Evidence for poor vitamin status in celiac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther. 2002;16:1333–1339. doi:10.1046/j.1365-2036.2002.01283.x.PubMedCrossRefGoogle Scholar
  42. 42.
    Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481–3488. doi:10.1161/CIRCULATIONAHA.105.537878.PubMedCrossRefGoogle Scholar
  43. 43.
    Pengiran Tengah DS, Wills AJ, Holmes J. Neurological complication of celiac disease. Postgrad Med J. 2002;78:393–399. doi:10.1136/pmj.78.921.393.PubMedCrossRefGoogle Scholar
  44. 44.
    Silano M, Volta U, De Vincenzi A, Sessì M, De Vincenzi M. Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci. 2008;53:972–976. doi:10.1007/s10620-007-9952-8.PubMedCrossRefGoogle Scholar
  45. 45.
    Tursi A, Brandimarte G, Giorgetti GM, Gigliobianco A. Endoscopic features of celiac disease in adults and their correlation with age, histological damage, and clinical form of the disease. Endoscopy. 2002;34:787–792. doi:10.1055/s-2002-34255.PubMedCrossRefGoogle Scholar
  46. 46.
    Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of coeliac disease: which is now the main form of coeliac disease in clinical practice? Minerva Gastroenterol Dietol. 2002;47:121–130.Google Scholar
  47. 47.
    Tursi A. Can histological damage influence the severity of coeliac disease? An unanswered question. Dig Liver Dis. 2007;39:30–32. doi:10.1016/j.dld.2006.09.009.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Antonio Tursi
    • 1
  • Walter Elisei
    • 2
  • Gian Marco Giorgetti
    • 3
  • Giovanni Brandimarte
    • 2
  • Fabio Aiello
    • 4
  1. 1.Digestive Endoscopy Unit“Lorenzo Bonomo” HospitalAndriaItaly
  2. 2.Department of Internal Medicine, Division of Gastroenterology“Cristo Re” HospitalRomeItaly
  3. 3.Clinical Nutrition Unit“S. Eugenio” HospitalRomeItaly
  4. 4.Department of Statistic and Mathematic SciencesUniversity of PalermoPalermoItaly

Personalised recommendations